Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).
about
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvementEfficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseasesTacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections.Therapeutic effect of 0.1% Tacrolimus Eye Ointment in Allergic Ocular Diseases.The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism.Inhibitory effects of steroidal timosaponins isolated from the rhizomes of Anemarrhena asphodeloides against passive cutaneous anaphylaxis reaction and pruritus.Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study.Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models.Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin.Pilot study of patient satisfaction with nonfluorinated topical steroids compared with a topical immunomodulator in atopiform dermatitis.A canine model of cutaneous late-phase reactions: prednisolone inhibition of cellular and cytokine responses.Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.Tacrolimus and topical steroids: which is more effective?FK506 aerosol locally inhibits antigen-induced airway inflammation in Guinea pigs.Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis.Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis.The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils.Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor.The Anti-Inflammatory Effects of Fermented Herbal Roots of in an Ovalbumin-Induced Asthma Model
P2860
Q33956479-2AE902CF-3B2E-44F8-AA61-9DCDF1D8E26BQ33960223-CA4DB2B3-3B49-410C-9E13-47A36F522384Q34554247-076EE666-52C8-4A91-9837-A9E6082B09D9Q36405134-4D85E284-5547-4154-8022-207A12D724D8Q36425959-B3EA1948-0716-470A-869D-4D90E80B7F27Q36596448-E893A318-641F-493F-B601-CB441AB74D39Q37512197-C474D1B4-D4EB-41DF-BFAE-C6B705B08FD6Q39168929-14924D77-83AB-4C48-A4C8-51EFA7C6D6E4Q41710566-3159BA31-B2A1-4546-AC09-5B2CCD1D4636Q43185927-899BF42E-5988-4E89-8025-F3AF852AFE85Q44099119-F520E6C7-2A93-42A9-90BC-BD999F87E4A1Q44655333-4685872D-04D5-4815-92ED-0ADFAE4FCFE4Q44665428-4CBCB83F-8C33-4AEE-9CF2-66A6ED37D540Q44792098-B4B0668C-FF44-4A02-A044-8ED157B20E38Q44864686-39011100-015A-44DB-9F91-4D5D32D56B54Q45120688-19E53CD0-4115-44A3-8962-1FEC7BEFBAA1Q45192172-86DE7457-91D1-4A25-A6E5-FAFBCA3706B6Q45299918-FEC4FB11-5A46-4631-BC76-58342B2DEC20Q46046521-199DF65B-D041-440B-B675-E6A89C084C58Q46539238-17E99CCD-3B76-4AEB-A4B9-F4DDF1A4120EQ48179750-2ACFFD2B-B1B7-46C7-B932-96D7F319FD66Q52034778-DB60FEE5-BDC7-4388-BB48-ADD8827112BBQ53289717-62022D43-49D4-4907-A511-5169825C251EQ58581556-71E3D801-8617-4C09-865D-42CA3F1D33D2
P2860
Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tacrolimus suppressed the prod ...... m. (Comparison with steroids).
@en
Tacrolimus suppressed the prod ...... mulation of human PBMC system.
@nl
type
label
Tacrolimus suppressed the prod ...... m. (Comparison with steroids).
@en
Tacrolimus suppressed the prod ...... mulation of human PBMC system.
@nl
prefLabel
Tacrolimus suppressed the prod ...... m. (Comparison with steroids).
@en
Tacrolimus suppressed the prod ...... mulation of human PBMC system.
@nl
P2093
P1476
Tacrolimus suppressed the prod ...... m. (Comparison with steroids).
@en
P2093
Sasakawa T
P304
P356
10.1016/S1567-5769(01)00059-5
P577
2001-06-01T00:00:00Z